Cargando…
Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines
HA15 is a new anti-melanoma drug that triggers endoplasmic reticulum (ER) stress and causes deleterious effects on melanoma cell viability due to autophagy and apoptosis, regardless of driver mutations or drug resistance. In this study, we investigated the effect of HA15 on the viability/proliferati...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908983/ https://www.ncbi.nlm.nih.gov/pubmed/33498201 http://dx.doi.org/10.3390/biomedicines9020096 |
_version_ | 1783655831455137792 |
---|---|
author | Szász, István Koroknai, Viktória Patel, Vikas Hajdú, Tibor Kiss, Tímea Ádány, Róza Balázs, Margit |
author_facet | Szász, István Koroknai, Viktória Patel, Vikas Hajdú, Tibor Kiss, Tímea Ádány, Róza Balázs, Margit |
author_sort | Szász, István |
collection | PubMed |
description | HA15 is a new anti-melanoma drug that triggers endoplasmic reticulum (ER) stress and causes deleterious effects on melanoma cell viability due to autophagy and apoptosis, regardless of driver mutations or drug resistance. In this study, we investigated the effect of HA15 on the viability/proliferation of BRAFV600E-mutant melanoma cells using different culture conditions. In contrast to the published data, we did not detect significant melanoma cell death under normal culture conditions using HA15 treatment. Indeed, only cells that were cultured under long-term starvation conditions were sensitive to the drug. Quantitative measurements of ER stress and autophagy markers showed that the compound HA15 does not trigger stress alone but synergistically enhances ER stress under starvation conditions. Importantly, we observed that the viability of normal melanocytes decreased significantly with treatment, even at low HA15 concentrations. Finally yet importantly, we were able to generate HA15-resistant cell lines, which failed by Cerezo et al. In summary, HA15 only influences the viability of cells that are starved for several hours before and during treatment. However, this in vitro setting is far from the in vivo conditions. In addition, our data clearly show that melanoma cells can acquire HA15 resistance. Further studies are needed to prove that HA15 is an effective anti-cancer agent. |
format | Online Article Text |
id | pubmed-7908983 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79089832021-02-27 Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines Szász, István Koroknai, Viktória Patel, Vikas Hajdú, Tibor Kiss, Tímea Ádány, Róza Balázs, Margit Biomedicines Article HA15 is a new anti-melanoma drug that triggers endoplasmic reticulum (ER) stress and causes deleterious effects on melanoma cell viability due to autophagy and apoptosis, regardless of driver mutations or drug resistance. In this study, we investigated the effect of HA15 on the viability/proliferation of BRAFV600E-mutant melanoma cells using different culture conditions. In contrast to the published data, we did not detect significant melanoma cell death under normal culture conditions using HA15 treatment. Indeed, only cells that were cultured under long-term starvation conditions were sensitive to the drug. Quantitative measurements of ER stress and autophagy markers showed that the compound HA15 does not trigger stress alone but synergistically enhances ER stress under starvation conditions. Importantly, we observed that the viability of normal melanocytes decreased significantly with treatment, even at low HA15 concentrations. Finally yet importantly, we were able to generate HA15-resistant cell lines, which failed by Cerezo et al. In summary, HA15 only influences the viability of cells that are starved for several hours before and during treatment. However, this in vitro setting is far from the in vivo conditions. In addition, our data clearly show that melanoma cells can acquire HA15 resistance. Further studies are needed to prove that HA15 is an effective anti-cancer agent. MDPI 2021-01-20 /pmc/articles/PMC7908983/ /pubmed/33498201 http://dx.doi.org/10.3390/biomedicines9020096 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Szász, István Koroknai, Viktória Patel, Vikas Hajdú, Tibor Kiss, Tímea Ádány, Róza Balázs, Margit Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines |
title | Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines |
title_full | Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines |
title_fullStr | Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines |
title_full_unstemmed | Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines |
title_short | Cell Proliferation Is Strongly Associated with the Treatment Conditions of an ER Stress Inducer New Anti-Melanoma Drug in Melanoma Cell Lines |
title_sort | cell proliferation is strongly associated with the treatment conditions of an er stress inducer new anti-melanoma drug in melanoma cell lines |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908983/ https://www.ncbi.nlm.nih.gov/pubmed/33498201 http://dx.doi.org/10.3390/biomedicines9020096 |
work_keys_str_mv | AT szaszistvan cellproliferationisstronglyassociatedwiththetreatmentconditionsofanerstressinducernewantimelanomadruginmelanomacelllines AT koroknaiviktoria cellproliferationisstronglyassociatedwiththetreatmentconditionsofanerstressinducernewantimelanomadruginmelanomacelllines AT patelvikas cellproliferationisstronglyassociatedwiththetreatmentconditionsofanerstressinducernewantimelanomadruginmelanomacelllines AT hajdutibor cellproliferationisstronglyassociatedwiththetreatmentconditionsofanerstressinducernewantimelanomadruginmelanomacelllines AT kisstimea cellproliferationisstronglyassociatedwiththetreatmentconditionsofanerstressinducernewantimelanomadruginmelanomacelllines AT adanyroza cellproliferationisstronglyassociatedwiththetreatmentconditionsofanerstressinducernewantimelanomadruginmelanomacelllines AT balazsmargit cellproliferationisstronglyassociatedwiththetreatmentconditionsofanerstressinducernewantimelanomadruginmelanomacelllines |